Latest Schedule 13G passive stakes

L1 Capital Global Opportunities Master Fund, Ltd. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 539,892 shares of BNB PLUS CORP. common stock, representing 7.0% of the class.

Several Biotechnology Value Funds and associated entities have updated their beneficial ownership filings for TScan Therapeutics, Inc., reporting their holdings as of June 30, 2026.

Alyeska Investment Group, L.P., along with its affiliates, has reported beneficial ownership of 4.86% of Abundia Global Impact Group, Inc.'s common stock as of June 30, 2026.

D. E. Shaw & Co., L.P., D. E. Shaw & Co., L.L.C., and David E. Shaw have filed an amendment to their Schedule 13G, updating their beneficial ownership information for Cable One, Inc.

Alyeska Investment Group, L.P., along with affiliated entities, has reported a beneficial ownership stake of 4.61% in USA Rare Earth, Inc., as of June 30, 2026.

HighSage Ventures LLC and Jennifer Stier have jointly filed a Schedule 13G, reporting a combined beneficial ownership of approximately 6.9% to 7% of Angi Inc.'s Class A Common Stock as of June 30, 2026.

Redmile Group, LLC, Jeremy C. Green, and RedCo II Offshore SPV LLC have updated their beneficial ownership filings for Nurix Therapeutics, Inc., collectively holding 8.1% and 3.5% of the common stock.

Encompass Capital Advisors LLC, Todd J. Kantor, and Encompass Capital Partners LLC have filed an amended Schedule 13G, reporting zero beneficial ownership of Rice Acquisition Corp's Class A common stock.

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have jointly filed a Schedule 13G, reporting beneficial ownership of 1.16% of Voyager Technologies, Inc.'s Class A Common Stock as of June 30, 2026.

J. Goldman & Co LP, along with affiliated entities, has reported beneficial ownership of 1,696,549 shares, representing 5.57% of Destiny Tech100 Inc.'s common stock.

TCG Crossover Fund III, L.P., TCG Crossover GP III, LLC, and Chen Yu have jointly reported beneficial ownership of 500,000 Class A Ordinary Shares, representing 6.4% of the outstanding shares in Research Alliance Corporation III.

Redmile Group, LLC and Jeremy C. Green have reported a beneficial ownership stake of 3.6% in Scholar Rock Holding Corporation, holding 4,311,092 shares.

Elliott Investment Management L.P. has reported beneficial ownership of 5.8% of Pinterest, Inc.'s Class A Common Stock as of June 30, 2026.

Encompass Capital entities and Todd J. Kantor report a combined 7.60% and 6.04% stake in EagleRock Land, LLC Class A shares as of June 30, 2026.

Select Equity Group, L.P. and George S. Loening have jointly reported beneficial ownership of 2,436,873 common shares, representing 6.2% of Signet Jewelers Ltd.

Discovery Capital Management, LLC, Robert K. Citrone, and Discovery Global Opportunity Master Fund, Ltd. have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of AMC Entertainment Holdings, Inc. Class A common stock.

Soros Fund Management LLC and George Soros have filed a Schedule 13G amendment, appointing attorneys-in-fact for executing regulatory filings related to securities ownership.

Leon G. Cooperman, through Capital L.P., has reported beneficial ownership of 3,261,216 shares, representing 12.4% of WhiteHawk Minerals Corp.'s Class A Common Stock.

Newtyn Management, LLC has filed a Schedule 13G amendment indicating it is an exit filing, reducing its beneficial ownership of Enviri Corp common stock to 1.3%.

Several Biotechnology Value Funds have updated their beneficial ownership filings for Nektar Therapeutics, reporting a combined stake of 7.1% as of June 30, 2026.

TCG Crossover Fund II, L.P., along with affiliated entities and individual Chen Yu, has increased its beneficial ownership in Tango Therapeutics, Inc. to 7.0%, acquiring 10,147,867 shares.

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed to report beneficial ownership of 5.0% of Neuronetics, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.5% of Future Money Acquisition Corporation's ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.5% of Future Money Acquisition Corporation's ordinary shares as of June 30, 2026.

Vestal Point Capital, LP, along with its Chief Investment Officer Ryan Wilder, has reported beneficial ownership of 5.4% of Monte Rosa Therapeutics, Inc. common stock.

Point72 Asset Management, L.P., along with related entities and Steven A. Cohen, has reported beneficial ownership of 1.4% of Sutro Biopharma, Inc.'s common stock as of June 30, 2026.

Southeastern Asset Management and Longleaf Partners Small-Cap Fund jointly report beneficial ownership of 5.4% of GCI Liberty's Series C GCI Group Common Stock as of June 30, 2026.

Southeastern Asset Management, Inc. and Longleaf Partners Small-Cap Fund report a combined 5.1% stake in Empire State Realty Trust, Inc. Class A Common Stock.

Southeastern Asset Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.6% of People Inc.'s common stock as of June 30, 2026.

Karpus Management, Inc. has updated its beneficial ownership filing for Oxford Lane Capital Corp.'s preferred stock, reporting a 6.08% stake.